Isogenica expands team
Isogenica is hiring to add strength and depth to our team and to increase our commitment to partnerships with biopharma.
Isogenica is increasing our commitment to partnerships with biopharma. We’ve seen important shifts in the way pharma and biotech want to engage with Isogenica, and we’re embracing the opportunity for change by adding strength and depth to our team so that we can continue to work as trusted partners with a wider group of pioneering biopharma companies. We’re recruiting to fill several vacancies including a newly created role of Director of Antibody Discovery and a Senior Scientist team lead role.
Posts will be advertised on our website now and over the coming weeks, so take a look and please get in touch if you, or someone you know, are interested in a role at Isogenica.
Further Information
Isogenica is developing LlamdA™ (single domain VHH) and Alexandria™ (human Fab) therapeutic antibodies from its proprietary fully synthetic antibody libraries and leveraging its CIS Display and Colibra™ technologies to accelerate the discovery and development process. Over the last four years
Isogenica has entered into eight significant partnerships, leveraging its libraries, technologies and expertise to build a broad pipeline of programs that are now advancing into pre-clinical and early clinical development with our partners.”
Contact
